We are live on ! Find out more
Lazard Asset Management

Lazard Asset Management Portfolio holdings

AUM $60.8B
1-Year Est. Return 22.47%
This Fund
S&P 500
This Quarter Est. Return
-12.43%
1 Year Est. Return
+22.47%
3 Year Est. Return
+62.53%
5 Year Est. Return
+77.87%
10 Year Est. Return
+302.07%
AUM
$73.9B
AUM Growth
-$12.4B
Cap. Flow
-$7.83B
Cap. Flow %
-10.58%
Top 10 Hldgs %
21.74%
Holding
2,664
New
311
Increased
910
Reduced
656
Closed
240

Top Buys

Rank Stock Value
1
NSC icon
Norfolk Southern
NSC
+$788M
2
UNP icon
Union Pacific
UNP
+$641M
3
ICLR icon
Icon
ICLR
+$463M
4
WFC icon
Wells Fargo
WFC
+$310M
5
CSX icon
CSX Corp
CSX
+$286M

Top Sells

Rank Stock Value
1
MDT icon
Medtronic
MDT
+$599M
2
ICE icon
Intercontinental Exchange
ICE
+$280M
3
PEP icon
PepsiCo
PEP
+$246M
4
FDX icon
FedEx
FDX
+$242M
5
CL icon
Colgate-Palmolive
CL
+$190M

Sector Composition

Rank Sector Weight
1 Technology 18.51%
2 Healthcare 14.98%
3 Financials 13.27%
4 Industrials 10.94%
5 Consumer Discretionary 8.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CWEN.A
2201
DELISTED
Clearway Energy Class A
CWEN.A
-883
Closed -$29K
CZNC icon
2202
Citizens & Northern Corp
CZNC
$456M
-979
Closed -$23K
CZR icon
2203
Caesars Entertainment
CZR
$6.05B
-279
Closed -$21K
DAL icon
2204
Delta Air Lines
DAL
$60B
$0 ﹤0.01%
34
DCO icon
2205
Ducommun
DCO
$2.73B
-655
Closed -$34K
DEA
2206
Easterly Government Properties
DEA
$1.16B
-746
Closed -$39K
DINO icon
2207
HF Sinclair
DINO
$16.3B
-1,329
Closed -$52K
DLTH icon
2208
Duluth Holdings
DLTH
$159M
-5,413
Closed -$66K
DOC icon
2209
Healthpeak Properties
DOC
$15.1B
$0 ﹤0.01%
16
-1,880
-99% -$57K
DT icon
2210
Dynatrace
DT
$13.1B
$0 ﹤0.01%
12
-5,000
-100% -$199K
ELAN icon
2211
Elanco Animal Health
ELAN
$12.8B
$0 ﹤0.01%
41
+22
+116% +$521
EMBC icon
2212
Embecta
EMBC
$221M
$0 ﹤0.01%
+2
New +$58
EPAC icon
2213
Enerpac Tool Group
EPAC
$1.85B
-4,693
Closed -$102K
EPR icon
2214
EPR Properties
EPR
$4.68B
-526
Closed -$28K
ERIC icon
2215
Ericsson
ERIC
$32.8B
-35,000
Closed -$319K
ERII icon
2216
Energy Recovery
ERII
$454M
-2,434
Closed -$49K
ESQ icon
2217
Esquire Financial Holdings
ESQ
$1.14B
-846
Closed -$28K
ESTA icon
2218
Establishment Labs
ESTA
$2.81B
-963
Closed -$64K
EWCZ
2219
DELISTED
European Wax Center
EWCZ
-40,247
Closed -$1.19M
EWJ icon
2220
iShares MSCI Japan ETF
EWJ
$22B
-125
Closed -$7K
FARO
2221
DELISTED
Faro Technologies
FARO
$0 ﹤0.01%
32
+17
+113% +$623
FBIO icon
2222
Fortress Biotech
FBIO
$88.4M
-328
Closed -$6K
FFWM
2223
DELISTED
First Foundation Inc
FFWM
$0 ﹤0.01%
+23
New +$509
FHN icon
2224
First Horizon
FHN
$12.2B
-1,345
Closed -$31K
FPH icon
2225
Five Point Holdings
FPH
$374M
-6,145
Closed -$37K

Similar funds

Lazard Asset Management's Q2 2022 Portfolio in Review

As of Q2 2022, Lazard Asset Management held 2,664 positions worth $73.9B, down 14% from $86.3B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Lazard Asset Management withdrew a net $7.83B in Q2 2022, closing 240 positions and reducing 656 holdings. Its most notable exit was ASPEN TECHNOLOGY INC, an estimated $156M position sold in full.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 19% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Lazard Asset Management opened a new position in Aspen Technology Inc worth $74.1M.

  • Lazard Asset Management's largest Q2 2022 buy was Aspen Technology Inc: 403,325 shares worth $74.1M.
  • Lazard Asset Management added most to Norfolk Southern in Q2 2022, an estimated $788M increase.
  • Lazard Asset Management's biggest Q2 2022 reduction was Medtronic, cutting an estimated $599M.
  • Lazard Asset Management fully exited ASPEN TECHNOLOGY INC in Q2 2022, selling an estimated $156M.
  • Lazard Asset Management's ten largest holdings make up 22% of its $73.9B portfolio in Q2 2022.
  • Lazard Asset Management opened 311 new positions and closed 240 in Q2 2022.
  • Lazard Asset Management's portfolio value fell 14% quarter-over-quarter to $73.9B.

Based on Lazard Asset Management's 13F filing for Q2 2022, filed 9 Aug 2022.